Snapshot from Aug 07, 2026 at 07:00 UTC. For live data and tracking: View Live
Business acquisition

Cardinal Health acquires AdaptHealth diabetes unit, Strive Medical

Analysis based on 8 articles · First reported Jul 20, 2026 · Last updated Jul 21, 2026

Sentiment
15
Attention
2
Articles
8
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The acquisitions are expected to strengthen Cardinal Health's home care business and expand its therapeutic reach, potentially boosting revenue and earnings. AdaptHealth's focus on its core sleep and respiratory businesses may improve its operational efficiency, while Strive Medical's addition enhances Cardinal Health's urology supply portfolio.

Healthcare Medical Equipment

Cardinal Health announced on July 20, 2026, that it has agreed to acquire AdaptHealth's Diabetes Health business and Strive Medical for a combined $360 million in cash. The acquisitions are intended to expand Cardinal Health's at-Home Solutions business, adding capabilities in diabetes management, urology, wound care, ostomy, and incontinence supplies. AdaptHealth's diabetes unit serves over 225,000 patients annually through a direct-to-patient mail-order model, while Strive Medical serves over 20,000 patients. The deals are expected to be accretive to non-GAAP earnings per share within 12 months of closing and build on Cardinal Health's prior acquisition of Advanced Diabetes Supply. JPMorgan Chase — JPMorgan Chase served as financial advisor to Cardinal Health. The transactions are subject to regulatory approvals and customary closing conditions.

stock
Cardinal Health is the acquirer, expanding its at-Home Solutions business and strengthening its position in diabetes and urology care. The deals are expected to be accretive to earnings.
Importance 100.0 Sentiment 15.0
stock
AdaptHealth divests its diabetes health business to focus on core sleep and respiratory care. The sale provides capital to strengthen its balance sheet and pursue growth in its core areas.
Importance 80.0 Sentiment 10.0
priv
Strive Medical is acquired by Cardinal Health, adding its urology, wound care, and incontinence supply capabilities to Cardinal's home care platform.
Importance 60.0 Sentiment 20.0
per
Jason Hollar, CEO of Cardinal Health, announced the acquisitions and highlighted their strategic fit with the company's at-Home Solutions growth strategy.
Importance 40.0 Sentiment 10.0
priv
Advanced Diabetes Supply, previously acquired by Cardinal Health, provides a framework for integrating the new diabetes business.
Importance 30.0 Sentiment 10.0
per
Suzanne Foster, CEO of AdaptHealth, stated that the divestiture is part of a strategy to focus on core sleep and respiratory businesses.
Importance 30.0 Sentiment 5.0
priv
NMS Capital, the owner of Strive Medical, exits the investment through the sale to Cardinal Health.
Importance 20.0 Sentiment 10.0
per
Rob Schlissberg, president of Cardinal Health at-Home Solutions, commented on the company's operational achievements and growth plans.
Importance 20.0 Sentiment 5.0
subs
JPMorgan Chase — JPMorgan Chase served as financial advisor to Cardinal Health on the transactions.
Importance 10.0 Sentiment 0.0
per
Michael Francis Crotty, an analyst at Leerink Partners, commented that the acquisitions are logical strategic tuck-ins for Cardinal Health.
Importance 10.0 Sentiment 0.0
priv
Leerink Partners provided analyst commentary on the acquisitions.
Importance 5.0 Sentiment 0.0
priv
Skadden, Arps, Slate, Meagher & Flom advised Cardinal Health on the AdaptHealth transaction.
Importance 5.0 Sentiment 0.0
priv
DLA Piper advised Cardinal Health on both the AdaptHealth and Strive Medical transactions.
Importance 5.0 Sentiment 0.0
priv
BakerHostetler advised Cardinal Health on the Strive Medical acquisition.
Importance 5.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.